Form 4: Elevance Health CAO & Controller Ronald W. Penczek Reports Sale of Common Stock

Ronald W. Penczek, CAO & Controller of Elevance Health, Inc., reported the sale of 443 shares of common stock at a price of $415.13 on March 10, 2025.

Summary

• On March 10, 2025, Ronald W. Penczek, the CAO & Controller of Elevance Health, Inc. (ELV), sold 443 shares of common stock.
• The transaction was executed at a price of $415.13 per share.
• Following the reported transaction, Penczek directly owns 1,847 shares of Elevance Health common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of the company are buying or selling shares.

Stakeholder Impact

• The sale of shares by a company insider could be perceived negatively by some shareholders, as it might suggest a lack of confidence in the company's future prospects, although this is a small transaction.

Key Dates